Documenting Site Capabilities in Regulatory Submissions
Documenting Site Capabilities in Regulatory Submissions How to Document Clinical Site Capabilities in Regulatory Submissions Introduction: Why Documenting Site Capabilities Matters As regulatory expectations evolve, sponsors are increasingly required to justify and document the selection of clinical trial sites in regulatory submissions. Whether submitting to the FDA, EMA, MHRA, PMDA, or CDSCO, demonstrating that each…
Read More “Documenting Site Capabilities in Regulatory Submissions” »